FDA Approves New Drug Vraylar

A new antipsychotic drug that can be used to treat schizophrenia and bipolar disorder in adults has been approved by the FDA. Vraylar belongs to a class of drugs known as atypical antipsychotics. Others in this group include Abilify (aripiprazole), Seroquel (quetiapine) and Risperdal (risperidone).
Source: Weird Cake: Myopic musings from a bipolar survivor - Category: Psychiatry Source Type: blogs